Receiving Radiation Therapy in the MRgRT Research Facility

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02701712

Acronym

MRgRT

Enrollment

150

Registered

2016-03-08

Start date

2016-02-01

Completion date

2027-02-01

Last updated

2026-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Tumors and Metastatic Lesions

Keywords

magnetic resonance, external beam radiotherapy, brachytherapy, radiotherapy

Brief summary

The aim of this study is to evaluate the technical performance of magnetic-resonance guided radiotherapy (MRgRT) facility at the Princess Margaret Cancer Centre and the impact on the workflow of the clinical team in this facility.

Interventions

RADIATIONMagnetic resonance - guided radiation therapy (MRgRT)

Use of magnetic resonance (MR) visualization for interventional radiotherapy in cancer patients

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ability to provide informed consent * Planned to receive clinical intervention (imaging or treatment) in the MRgRT facility * At least 18 years of age

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Proportion of planned patients receiving treatment in the MRgRT facility	2 years

Secondary

Measure	Time frame	Description
Measure tumor size before, during and after radiotherapy	2 years	Collect and analyze imaging data before, during and after radiotherapy, and the related treatment data

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORMichael Milosevic, MD

University Health Network, Toronto

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026